Table 1.
Demographics and clinical characteristics of 54 deceased patients with COVID-19.
| Patients (n = 54) | |
| Median age, ys (IQR) | 67 (62-75) |
| ≥60 | 43 (80%) |
| Sex | |
| Male | 39 (72%) |
| Female | 15 (28%) |
| Symptoms of onset | |
| Fever | 46 (85%) |
| Cough | 39 (72%) |
| Dyspnoea | 25 (46%) |
| Fatigue | 24 (44%) |
| Chest tightness | 11 (20%) |
| Myalgia | 6 (11%) |
| Vomiting | 3 (6%) |
| Diarrhoea | 10 (19%) |
| Headache | 9 (17%) |
| Comorbidities | |
| Hypertension | 23 (43%) |
| Diabetes | 11 (20%) |
| Coronary heart disease | 10 (19%) |
| Chronic lung diseases | 8 (15%) |
| Malignancy | 2 (4%) |
| Chronic renal failure | 1 (2%) |
| Smoking history | 20/40 (50%) |
| Male smoker | 19/27 (70%) |
| Female smoker | 1/13 (8%) |
| Treatments | |
| Non-invasive mechanical ventilation | 22 (41%) |
| Invasive mechanical ventilation | 41 (76%) |
| ECMO | 2 (4%) |
| Time of outcomes | |
| Median (IQR) time from onset of symptom to death, days | 30 (23-35) |
| Median (IQR) time from hospital admission to death, days | 17 (11-22) |
| Median (IQR) time from final chest X-ray to death, days | 3 (1-4.25) |